Geneos Wealth Management Inc. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 195 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$839
-19.7%
1080.0%0.00%
Q2 2023$1,045
-11.7%
1080.0%0.00%
Q1 2023$1,1841080.0%0.00%
Q3 2022$0
-100.0%
108
-96.7%
0.00%
-100.0%
Q2 2022$36,000
-10.0%
3,233
-0.5%
0.00%0.0%
Q1 2022$40,000
-16.7%
3,250
+54.2%
0.00%0.0%
Q4 2021$48,000
+6.7%
2,1080.0%0.00%0.0%
Q3 2021$45,000
+1400.0%
2,108
+717.1%
0.00%
Q2 2021$3,000
-78.6%
258
-76.7%
0.00%
Q1 2021$14,000
+180.0%
1,1080.0%0.00%
Q4 2020$5,0001,1080.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders